The 5-Cog Paradigm Improves Diagnosis, Management of Dementia
By Elana Gotkine HealthDay Reporter
TUESDAY, June 11, 2024 -- For older adults with cognitive concerns, the 5-Cog paradigm, a culturally adept, cognitive detection tool, paired with a clinical decision support, can improve diagnosis and management of dementia, according to a study published online June 4 in Nature Medicine.
Joe Verghese, M.B.B.S., from the Albert Einstein College of Medicine in New York City, and colleagues conducted a randomized controlled trial in primary care patients experiencing health disparities to examine whether the 5-Cog paradigm can reduce barriers to dementia diagnosis and care. Older adults with cognitive concerns were allocated to the 5-Cog paradigm or control in a 1:1 ratio (599 and 602, respectively).
The researchers found that compared with the control, the 5-Cog paradigm demonstrated threefold odds of improvement in dementia care actions, defined as any of the following end points within 90 days: new mild cognitive impairment syndrome or dementia diagnoses as well as investigations, medications, or specialist referrals ordered for cognitive indications (odds ratio, 3.43). There were no reports of serious intervention-related adverse events.
"The 5-Cog paradigm helped to improve dementia care actions related to diagnosis, investigations, and treatments that account for many implementation barriers and racial/ethnic differences in primary care patients presenting with cognitive concerns," the authors write. "This trial provides the evidence base to develop cognitive detection guidelines to promote practice change in primary care."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted June 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.